dc.contributorTorres De Galvis, Yolanda
dc.creatorBartolomeu Zúñiga, Manuel Ernesto
dc.date.accessioned2020-07-13T18:07:00Z
dc.date.accessioned2022-09-22T14:11:24Z
dc.date.available2020-07-13T18:07:00Z
dc.date.available2022-09-22T14:11:24Z
dc.date.created2020-07-13T18:07:00Z
dc.identifierhttps://repository.urosario.edu.co/handle/10336/25398
dc.identifierhttps://doi.org/10.48713/10336_25398
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3436602
dc.description.abstractBACKGROUND. Osteoporosis (OP) is a disease that affects the skeleton of the bone and produces a series of alterations where the result is a decrease in bone mass that ultimately results in an increase in bone fragility, with the consequent tendency to fracture. OBJECTIVE. To determine the prevalence of the degree of bone demineralization, measured by the DXA technique (dual X-ray absorptiometry, bone densitometry) in the lumbar spine and hip, in a population of women between the ages of 45 and 75, diagnosed with rheumatoid arthritis ( AR), that meet the EULAR / ACR criteria and thus be able to determine its possible relationship with the clinical and demographic factors of the patients to be studied. METHODOLOGY. Cross-sectional analytical observational study in 278 patients treated at the IPS Riesgo de Fractura S.A. CAYRE, in the city of Bogotá. The prevalence of bone demineralization, the prevalence or disparity ratio (RP) and the 95% confidence intervals (CI) were estimated, applying the logistic regression model to control for confounding variables. RESULTS. A prevalence of bone demineralization or low bone density was found in 17% of the sample and when calculating each of the vertebrae separately, a prevalence was observed in L1: 24%, L2: 23%, L3: 37%, L4 : 37% and hip: 29%. The variables that presented statistical significance in the bivariate analysis were included in the multivariate analysis, these were, age between 45 to 60 years with a RP of 9.09 with 95% CI between 3.78 and 29.67 and the normal value of the DAS28 scale with a RP of 3.49 with a 95% CI between 1.17 and 10.41, accepting its association as risk factors that influence bone demineralization. DISCUSSION. In the present study, a low prevalence of demineralization was found, compared to that reported in the literature.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherMaestría en Epidemiología
dc.publisherMaestría en Actividad Física y Salud
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombia
dc.sourceSolomon DH, Katz JN, Cabral D, Patrick AR, Bukowski JF, Coblyn JS. Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement. Arthritis Rheum. 2006; 55:873-7.
dc.sourceNolla JM, Gomez-Vaquero C, Romera M, Roig-Vilaseca D, Rozadilla A, Mateo L, et al. Osteoporotic vertebral fracture in clinical practice. 669 patients diagnosed over a 10 year period. J Rheumatol. 2001; 28:2289-93.
dc.sourceWorld Health Organization. (2003). Prevention and management of osteoporosis. (Informe No. 921). Ginebra: WHO Scientific Group.
dc.sourceStein E, Shane E. Secondary osteoporosis. Endocrinol Metab Clin N Am 2003; 32: 115-134.
dc.sourceFitzpatrick L. Secondary causes of osteoporosis. Mayo Clin Proc 2002; 77: 453-468.
dc.sourceZanchetta, J., and S. MacDonald. "Auditoría Regional de América Latina. Epidemiología, costos e impacto de la osteoporosis en 2012." Obtenido de International Osteoporosis Foundation: http://osteoporosisinlatinamerica. com/es/key-findings-in-latinamerica-in-2012.
dc.sourceClark P, Cons-Molina F, Delezé M, Ragi-Eis S, Haddock L, Zanchetta JR, Jaller JJ, Palermo L, Talavera JO, Messina DO, Morales-Torres, Salmeron J, Navarrete A, Suarez E, Pérez CM, Cummings SR (2009) The prevalence of vertebral fractures in Latin American countries: The Latin-American Vertebral Osteoporosis Study (LAVOS). Osteoporos Int 2009:275-282.
dc.sourceCarmona F (1999) Osteoporosis en Santa Fe de Bogatá. Instituto Nacional de Salud, Santa Fe de Bogatá
dc.sourceClark P, Chico G, Carlos F, Zamudio F, Pereira RMR, Zanchetta J, et al. Osteoporosis in Latin America: panel expert review. Medwave 2013;13(8):e5791
dc.sourceArdila E Epidemiology of Osteoporosis in Colombia (2001) (Abstract). Bone 29:297
dc.source. Guler-Yuksel, J. Bijsterbosch, Y.P. Goekoop-Ruiterman, J.K. de Vries-Bouwstra, H.K. Ronday, et al., Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis, Ann. Rheum. Dis. 66 (2007) 1508–1512.
dc.sourceCarmona F. Osteoporosis en Santa Fe de Bogotá. Santa Fe de Bogotá, Colombia: Instituto Nacional de Salud, 1999.
dc.sourceMorales-Torres J, Gutiérrez-Ureña S, Osteoporosis Committee of PANLAR (2004) the Burden of Osteoporosis in Latin America. Osteoporos Int 15:625-632
dc.sourceOrstavik RE, Haugeberg G, Uhlig T, et al. Vertebral deformities in 229 female patients with rheumatoid arthritis: associations with clinical variables and bone mineral density. Arthritis Rheum. 2003;49:355–60
dc.sourceDeodhar AA, Woolf AD. Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 1996; 35:309–22.
dc.sourceHooyman JR, Melton LJ III, Nelson AM, O’Fallon WM, RiggsBL. Fractures after rheumatoid arthritis: a population-based study. Arthritis Rheum 1984; 27:1353–61
dc.sourcePeel NF, Moore DJ, Barrington NA, Bax DE, Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 1995;54: 801–6.
dc.sourceSpector TD, Hall GM, McCloskey EV, Kanis JA. Risk of vertebral fracture in women with rheumatoid arthritis. BMJ 1993;306:558.
dc.sourceIbanez M, Ortiz AM, Castrejon I, et al. A rational use of glucocorticoids inpatients with early arthritis has a minimal impact on bone mass. Arthritis Res Ther.2010;12:R50.
dc.sourceDEAL, Chad. Bone loss in rheumatoid arthritis: systemic, periarticular, and focal. Current rheumatology reports, 2012, vol. 14, no 3, p. 231-237.
dc.sourceRoux C. 2011 Osteoporosis in inflammatory joint diseases. Osteoporos Int 22:421e433.
dc.sourceLodder MC, de Jong Z, Kostense PJ, et al. 2004 Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. Ann Rheum Dis 63:1576e1580.
dc.sourceLodder MC, Haugeberg G, Lems WF, et al. 2003 Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative study. Arthritis Rheum 49:209e215.
dc.sourceSinigaglia L, Nervetti A, Mela Q, et al. 2000 A multicenter cross sectional study on bone mineral density in rheumatoid arthritis.Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol 27:2582e2589
dc.sourceHaugeberg G, Uhlig T, Falch JA, et al. 2000 Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 43:522e530.
dc.sourceGough AK, Lilley J, Eyre S, et al. 1994 Generalized bone loss in patients with early rheumatoid arthritis. Lancet 344:23e27.
dc.sourceKinjo M, Setoguchi S, Solomon D. Bone mineral density in older adult patients with rheumatoid arthritis: an analysis of NHANES III. J Rheumatol 2007;34:1971_5.
dc.sourceØrstavik RE, Haugeberg G, Mowinckel P et al. Vertebral deformities in rheumatoid arthritis: a comparison with population based controls. Arch Intern Med 2004;164:420_5.
dc.sourceHaugeberg G, Uhlig T, Falch JA et al. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 2000;43:522_30.
dc.sourceHaugeberg G, Uhlig T, Falch JA et al. Reduced bone mineral density in male rheumatoid arthritis patients: frequencies and associations with demographic and disease variables in ninety-four patients in the Oslo County Rheumatoid Arthritis Register. Arthritis Rheum 2000;43:2776_2784.
dc.sourceVan Staa T, Geusens P, Bijlsma J et al. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 2006; 54: 3104_12.
dc.sourcePeris P, Guan˜abens N, Martı´nez de Osaba MJ, Monegal A,A´ lvarez L, Pons F, et al.Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum. 2002; 32:64–70.
dc.sourceNIH Consensus Development Panel. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001; 285:785–95.
dc.sourceMartin JC, Munro R, Campbell MK, Reid DM. Effects of disease and corticosteroids on appendicular bone mass in postmenopausal women with rheumatoid arthritis: comparison with axial measurements. Br J Rheumatol 1997;36:43–9.
dc.sourceKanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet.2002;359:1929–36.
dc.sourceKroger H, Honkanen R, Saarikoski S, Alhava E. Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis—a population based study. Ann Rheum Dis 1994;53: 18–23.
dc.sourceKvien TK, Glennås A, Knudsrød OG, Smedstad LM, Mowinckel P, Førre Ø. The prevalence and severity of rheumatoid arthritis in Oslo: results from a county register and a population survey. Scand J Rheumatol 1997;26:412–8.
dc.sourceConsensus Development Conference. Prophylaxis and treatment of osteoporosis. Am J Med 1991;90:107–10
dc.sourceAmerican College of Rheumatology Task Force on Osteoporosis Guidelines. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 1996;39: 1791–801.
dc.sourceLems WF, Dijkmans BA. Should we look for osteoporosis in patients with rheumatoid arthritis? Ann Rheum Dis 1998;57: 325–7.
dc.sourceKanis J, Melton L, Christiansen C, Johnston C, Khaltaev N. The diagnosis ofosteoporosis. J Bone Miner Res 1994;9:1137-41.
dc.sourceAssessment of fracture risk and its application to screening for postmenopausalosteoporosis: report of a WHO Study Group. Geneva: WHO; 1994. Tech. rep. series.
dc.sourceSouth Paul J, Osteoporosis: Part I. Evaluation and Assessment. AAFP 2001;63:897-904
dc.sourceBrunader R, Shelton D. Radiologic Bone Assessment in the evaluation ofosteoporosis.AAPF 2002;65:1357-64.
dc.sourceAletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham 3rd CO, et al.2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. AnnRheum Dis. 2010;69:1580–8.
dc.sourceOrganización Panamericana de la Salud. OPS. (1995). Clasificación estadística internacional de enfermedades y problemas relacionados con la salud. La organización Recuperado de: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/INTOR/CIE 10.zip
dc.sourceSvensson B, Andersson MLE, Bala S, et al Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria BMJ Open 2013;3:e003554. doi: 10.1136/bmjopen-2013-003554
dc.sourceUgarte-Gil Manuel F, Acevedo-Vásquez Eduardo M, Alarcón Graciela S. Terapia biológica en enfermedades reumatológicas. Rev Med Hered [Internet]. 2013 Abr [citado 2017 Dic 08] ; 24( 2 ): 141-155. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1018130X2013000200008&lng=es
dc.sourceGonzález Naranjo, Luis Alonso, & Molina Restrepo, José Fernando. (2010). Evaluación de la inflamación en el laboratorio. Revista Colombiana de Reumatología, 17(1), 35-47
dc.sourcePONTÓN, RB Ching, et al. Factores de riesgo para osteoporosis y osteopenia en 707 mujeres seleccionadas en Bogotá. Revista Española de Enfermedades Metabólicas Oseas, 2001, vol. 10, no 3, p. 86-9
dc.sourceHauser B, Riches P, Ralston S. Predictors of osteoporosis in rheumatoid arthritis: Retrospective cohort study. Bone. 2012;50:S135
dc.sourceAdami G, Fassio A, Rossini M, et al. Osteoporosis in Rheumatic Diseases. Int J Mol Sci. 2019;20(23):5867. Published 2019 Nov 22. doi:10.3390/ijms20235867
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectArtritis reumatoidea
dc.subjectOsteoporosis
dc.subjectDensidad mineral ósea
dc.subjectColumna lumbar
dc.subjectCadera
dc.titleMasa ósea de la columna lumbar y cadera en pacientes diagnosticados con artritis reumatoidea: prevalencia y factores asociados
dc.typemasterThesis


Este ítem pertenece a la siguiente institución